Indian Contract Development and Manufacturing Organisations (CDMOs) like Suven Pharmaceuticals, Syngene International, Laurus Labs, and Divi’s Laboratories are witnessing a surge in demand as global pharma players seek to reduce dependence on...
Biocon Biologics has accomplished a major breakthrough in the U.S. with wide-ranging market access for Yesintek (ustekinumab-kfce), its biosimilar to Stelara, marking its first commercial launch in the country as a fully combined biosimilar company.
A leading contract research and manufacturing organization, Akums Drugs & Pharmaceuticals, has established a patent for its novel extended-release invention of doxylamine and pyridoxine.
The New England Journal of Medicine recently published a study of semaglutide. This trail was conducted across 37 countries over 253 sites.
The Rajasthan Government has started the revival of Rajasthan Drugs and Pharmaceuticals Limited (RDPL), a Central Public Sector Undertaking (CPSU) in the state. RDPL is owned by the Central Government, which owns 51 percent, and the Rajasthan Governm
The Center-run RML Hospital has launched a heatstroke helpline, 011-23404446, for the public to report heat stroke patients in order to ensure prompt intervention amid the forecast of a sweltering summer in nort...
Remidio Innovative Solutions Pvt. Ltd., a leader in ophthalmic technology, has announced that it has received approval from the State FDA, Karnataka (CDSCO), the regulatory authority for medical devices, for its Medios HI (Humanizing Intellige...
In a timely and impactful initiative, Merck Specialities, in collaboration with leading hospitals across India, has launched the “Two-Minute Action Oral Cancer Protection” campaign with the hashtag #ActAgainstOralCancer.
The Securities and Exchange Board of India (SEBI) is to launch a Rs. 800 crore Initial Public Offering (IPO) with the Draft Red Herring Prospects (DRHP)
Tapentadlol is used for patients who have limited substitute treatment options and for pain.
, CDSCO.jpg)
